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Abstract
The occurrence of micropollutants (MPs) in various streams of municipal wastewater
treatment plants (WWTPs), and their fate and removal processes are discussed. The fate
of MPs in WWTPs largely depends on adsorption on suspended particulates, primary
and  secondary  sludge  and  dissolved  organic  carbon,  and  removal  occurs  due  to
coagulation‐flocculation,  and biodegradation.  The log Kow (>2.5)  and pKa are  the
dominant properties of the MPs, and the concentration, organic fraction, and surface
charge of suspended particulates dictate the extent of adsorption of MPs. Most of the
conventional WWTPs do not remove complex MPs by biodegradation or biotransfor‐
mation effectively (kbio ≤0.0042 L/gss/h), and the removal varies widely for different
compounds, as well as for the same substance, due to operational conditions such as
aerobic,  anaerobic,  anoxic,  sludge  retention  time  (SRT),  pH,  redox  potential,  and
temperature.  Membrane  bioreactor  performs  better  for  moderately  biodegradable
compounds due to the diverse nature of microorganisms as well as greater adaptability
due to longer SRT. Ozone and UV‐based advanced oxidation processes, membrane
filtration can be used for tertiary treatment due to their  high rate as well  as  easy
implementation. Various partition coefficients and rate constants values for different
MPs are also provided for design and application.
Keywords: micropollutants, wastewater, fate and removal, adsorption, coagulation,
biodegradation, membrane filtration, advanced oxidation processes
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1. Introduction
The widespread presence of micropollutants (MPs) in aquatic systems is a major concern all
across the globe. For example, about 143,000 compounds were registered in European market
in 2012; many of which would end up in water systems at some point of their lifecycle. Most of
them are not eliminated or biotransformed in traditional wastewater treatment plants, can be
persistent in aquatic system or form new chemical species reacting with background humic
substances in sunlight, can be bioactive, and can bioaccumulate [1–5]. Although they are present
in almost undetectable (low to subparts per billion (ppb)) concentrations, their existence in
aquatic  systems has been connected to various detrimental  effects  in  organisms such as
estrogenicity, mutagenicity, and genotoxicity [6].
While no compound‐specific regulation exists anywhere for the removal of MPs in wastewater
plants, some regulations are there for the presence in water for compounds such as pesticides,
lindane, nonylphenol, and synthetic hormones [7]. The MPs fall into several categories as
pharmaceuticals, personal care products (PPCPs), household chemicals, and industrial agents.
A comprehensive list of 242 chemicals is provided in EU FP7 Project [8] of which about 70% are
pharmaceuticals and personal care products and 30% are industrial agents including perfluoro
compounds, pesticides, herbicides, and food additives. Since a significant majority of the MPs
in municipal wastewater belong to the class of pharmaceuticals and personal care products
(PPCP), fate and removal processes of these compounds are discussed in detail in this chapter.
2. Commonly found PPCP in wastewater effluent and surface water
About 70% of the pharmaceuticals in the wastewater originates from household, 20% comes
from livestock farming, 5% is from hospital effluent, and rest 5% comes in runoff from
nonparticular sources [9]; however, seasonal and geographical variations typically occur. The
fate of MPs in wastewater plant depends on the physical properties such as solubility, octanol‐
water partition coefficient, and Henry’s constant. A list of commonly found pharmaceuticals,
personal care products, and biocides and their concentration in wastewater effluent and
surface water and physical properties are presented in Table 1. The solubility of MPs varies in
a wide range of 0.15 mg/L (maprotiline, C10 H23 N, an antidepressant drug) to 588,000 mg/L
(acesulfame, C4H4KNO4S, and artificial sweetener), which is also in accordance with their
concentration in the effluent.
Type MP Application Average
concentration
(ng/L) [10, 11]
Solubility*
(mg/mL)
log
Kow*
pKa* Henry’s
constant
(atm-m3/
mole)*Surface
water
WWTP
effluent
Disinfectants,
pharmaceuticals
(prescriptions, over‐
Atenolol β‐blocker 205 843 0.3 0.16 9.6 1.37 ×
E‐18
Azithromycin Antibiotic 12 175 <1 at 25°C 4.02 8.74 5.30 ×
E‐29
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Type MP Application Average
concentration
(ng/L) [10, 11]
Solubility*
(mg/mL)
log
Kow*
pKa* Henry’s
constant
(atm-m3/
mole)*Surface
water
WWTP
effluent
the‐counter drugs,
veterinary drugs)
[10]
Bezafibrate Lipid‐lowering
drug
24 139 0.00155 3.97 3.83
Carbamazepine Anticonvulsant 13 482 0.152 2.1 15.96 1.08 ×
10−10
Carbamazepin‐10,
11–dihydro‐10, 11‐
dihydroxy
Transformation
product
490 1551 – – – –
Clarithromycin Antibiotic 30 276 0.00033 3.16 8.99 at
25°C
1.73 ×
E‐29
Diatrizoate
(amidotrizoic acid)
Contrast medium 206 598 0.107 2.89 2.17 –
Diclofenac Analgesic 65 647 0.00447 4.98 4 4.73 ×
E‐12
Erythromycin Antibiotic 25 42 0.459 2.37 12.44 1.46 ×
E‐29
Ethinylestradiol Synthetic estrogen 5 2 0.00677 3.63 10.33 7.94 ×
E‐12
Ibuprofen Analgesic 35 394 0.0684 3.5 4.85 1.50 ×
E‐07
Iomeprol Contrast medium 275 380 – – – –
Iopamidol Contrast medium 92 377 0.117 1.62 4.15 1.14 ×
E‐25
Iopromide Contrast medium 96 876 0.0238 −2.05 – 1.00 ×
E‐28
Mefenamic acids Analgesic 7 870 0.0137 4.58 3.89 2.57 ×
E‐11
Metformin Antidiabetic 713 10347 1.38 −1.8 12.4 –
Metoprolol β‐blocker 20 166 0.402 1.88 14.09 1.40 ×
E‐13
Naproxen Analgesic 37 462 0.0511 3.29 4.19 3.39 ×
E‐10
Sotalol β‐blocker 63 435 0.782 0.85 10.07 2.49 ×
E‐14
Sulfamethoxazole Antibiotic 26 238 0.459 0.79 6.16 6.42 ×
E‐13
N4‐Acetylsulfame
thoxazole
Transformation
product
3 67 – – – –
Trimethoprim Antibiotic 13 100 0.615 1.26 17.33 2.39 ×
E‐14
Penicillin V Personal care
product
– 28.7 0.454 1.78 3.39 4.42 ×
E‐15
Disinfectants,
pharmaceuticals
(prescriptions, over‐
the‐counter drugs,
veterinary drugs)
[11]
Irbesartan Antihypertensives – 479.5 0.00884 4.51 7.4 –
Tramadol Analgesics – 255.8 0.75 2.71 13.8 1.54 ×
E‐11
Risperidone Neuroleptics – 6.9 0.171 3.27 8.76 –
Trihexyphenidyl Antidementia
agents
– 0.2 0.00314 4.93 13.84 4.73 ×
E‐10
Venlafaxine Antidepressant – 118.9 0.23 2.69 14.42 –
Codeine Morphine
derivates 
– 70.6 0.577 1.2 13.78 7.58 ×
E‐14
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Type MP Application Average
concentration
(ng/L) [10, 11]
Solubility*
(mg/mL)
log
Kow*
pKa* Henry’s
constant
(atm-m3/
mole)*Surface
water
WWTP
effluent
Fluconazole Antifungal
medication
– 108.2 1.39 0.58 12.71 –
Diphenhydramine Antihistamine – 11.7 0.0752 3.44 8.98 3.70 ×
E‐09
Repaglinide Antidiabetic
medications
– 3.1 0.00294 5.05 3.68 –
Flecainide Antiarrhythmic
agents
– 45.5 0.0324 2.98 13.68 5.75 ×
E‐13
Bisoprolol β‐blockers – 41.6 0.0707 2.3 14.09 2.89 ×
E‐15
Alfuzosin Alpha‐blockers – 2.8 0.282 2.02 14.64 –
Bupropion Antidepressant – 1.0 312 3.6 18.29 –
Ciprofloxacin Antibiotics – 96.3 1.35 0.28 6.09 5.09 ×
E‐19
Oxazepam Anxiolytics – 161.7 0.0881 2.24 10.61 5.53 ×
E‐10
Carbamazepine Antiepileptic drugs – 832.3 0.152 2.45 15.96 1.08 ×
E‐10
Diclofenac Analgesics 65 647 0.00447 4.98 4 4.73 ×
E‐12
Orphenadrine Antihistamine – 3.9 0.03 3.77 8.91 4.08 ×
E‐09
Sulfamethoxazole
(VITO)
Antibiotics – 280.2 0.459 0.89 6.16 –
Haloperidol Psychiatric
medication
– 32.2 0.00446 4.30 8.66 2.26 ×
E‐14
Citalopram Antidepressant – 33.8 – – – –
Sulfamethoxazole
(JRC)
Antibiotics – 142.3 0.459 0.89 6.16 –
Fexofenadine Antihistamine – 165.0 0.00266 5.6 4.04 –
Diltiazem Antiarrhythmic
agents
– 10.7 0.0168 3.09 12.86 8.61 ×
E‐17
Fluoxetine Antidepressant – 2.1 0.0017 4.05 9.8 8.90 ×
E‐08
Terbutaline Antiasthmatics – 1.1 5.84 0.90 8.86 1.65 ×
E‐18
Clindamycin Antibiotics – 70.4 3.1 2.16 12.16 2.89 ×
E‐22
Telmisartan Antihypertensives – 367.5 0.0035 7.7 3.65 –
Eprosartan Antihypertensives – 226.8 0.00866 3.9 3.63 –
Gemfibrozil Lipid‐lowering
drugs
– 137.7 0.0278 3.4 4.42 –
Zolpidem Hypnotics – 1.5 0.0313 3.15 6.2 –
Hydroxyzine Antihistamine – 1.1 0.0914 3.43 15.12 –
Ketoprofen Analgesics – 86.0 0.0213 3.12 4.45 2.12 ×
E‐11
Ranitidine Antihistamine – 68 0.0795 0.27 8.08 3.42 ×
E‐15
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Type MP Application Average
concentration
(ng/L) [10, 11]
Solubility*
(mg/mL)
log
Kow*
pKa* Henry’s
constant
(atm-m3/
mole)*Surface
water
WWTP
effluent
Triclosan Disinfectants – 74.8 0.00605 5.53 7.9 4.99 ×
E‐09
Levamisole Antihelminthics – 40.6 1.44 1.84 6.98 4.03 ×
E‐10
Lincomycin Antibiotics – 31.2 29.3 0.56 12.37  3.00 ×
E‐23
Rosuvastatin Statins – 31.0 0.0886 1.47 4 –
Mianserin Antidepressant – 1.5 0.232 3.52 6.92 –
Clofibric acid Lipid‐lowering
drugs
– 5.3 0.583 2.57 −4.9 2.19 ×
E‐08
Iohexol Radiocontrast
agents
– 158 0.796 −3.05 11.73 2.66 ×
E‐29
Memantine Antidementia
agents
– 22.8 0.0455 3.28 10.7 1.47 ×
E‐05
Sertraline Antidepressant – 2.1 0.000145 5.06 9.85 –
Tiamulin Antibiotics – 3.3 – – – –
Clonazepam Anticonvulsant – 1.6 0.0106 2.41 11.89 7.02 ×
E‐13
Alprazolam Antidepressant – 1.3 0.0324 2.12 18.3 9.77 ×
E‐12
Fenofibrate Lipid‐lowering
drugs
– 1.1 0.000707 4.86 −4.9 –
Sulfadiazine Antibiotics – 3.5 0.601 −0.09 6.36 1.58 ×
E‐10
Tilmicosin Antibiotics – 3.1 – – – –
Cyproheptadine Chemotherapeutic
agents
– 3.9 0.0136 4.69 8.05 9.20 ×
E‐09
Detergents,
dishwashing
liquids, personal care
products (fragrances,
cosmetics,
sunscreens), and
food products [11]
Methylbenzotriazole Personal care
product
– 2900 0.366 2.720 8.55 4.13 ×
E‐07
Gadolinium Personal care
product
– 115.0 – – – –
Loperamide Personal care
product
– 29.3 0.00086 4.44 13.96 –
Buprenorphine Personal care
product
– 3.9 0.0168 4.98 8.31 at
25°C
1.76 ×
E‐17
Maprotiline Personal care
product
– 0.4 0.00015 4.89 10.54 –
Duloxetine Personal care
product
– 0.1 0.00296 4.72 9.7 –
Miconazole Personal care
product
– 0.2 0.000763 5.86 6.77 –
Chlorpromazine Personal care
product
– 0.1 0.00417 5.18 9.3 at
25°C
3.95 ×
E‐11
Flutamide Personal care
product
– 0.1 0.00566 3.35 13.17 3.73 ×
E‐10
DEET, N, N’‐
diethyltoluamide
Personal care
product
– 678.1 0.912 2.80 2.08 ×
E‐08
Caffeine Food additives – 191.1 11.0 −0.07 10.4 at
40°C
1.90 ×
E‐19
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Type MP Application Average
concentration
(ng/L) [10, 11]
Solubility*
(mg/mL)
log
Kow*
pKa* Henry’s
constant
(atm-m3/
mole)*Surface
water
WWTP
effluent
Acesulfame Food additive 4010 22500 588 −1.33 5.67 –
Sucralose Food additive 540 4600 22.7 −1.00 4.2 –
Pesticides [10] Diazinon Insecticide 15 173 0.04 3.81 2.6 1.13 ×
E‐07
Diethyltoluamide
(DEET)
Insecticide 135 593 0.912 2.80 2.08 ×
E‐08
Dimethoate Insecticide 22 – 25 0.78 1.05 ×
E‐10
MCPA Insecticides – 149.9 0.63 3.25 3.13 1.33 ×
E‐09
Carbaryl Insecticide – 1.6 0.11 2.36 10.4 –
Biocides [10] 2, 4‐D Herbicide 67 13 0.012 2.81 2.73 1.59 ×
E‐07
Carbendazim Fungicide 16 81 0.029 1.52 4.2 2.12 ×
E‐11
Diuron Herbicide 54 201 0.042 2.68 5.04 ×
E‐10
Glyphosate Herbicide 373 – 12 −3.40 0.8 4.08 ×
E‐19
Irgarol (cybutryne) Herbicide 3 30 – – – –
Isoproturon Herbicide 315 12 0.065 2.87 1.12 ×
E‐10
MCPA Herbicide 40 25 0.63 3.25 3.13 1.33 ×
E‐09
Mecoprop‐p Herbicide 45 424 0.62 3.13 3.1 1.82 ×
E‐08
Triclosan Microbiocide 20 116 0.010 4.76 7.9 4.99 ×
E‐09
Terbutylazine Herbicide – 90.6 0.0085 3.21 2 3.72 ×
E‐08
Atrazine Herbicide – 4.2 0.0347 2.61 1.7 2.36 ×
E‐09
Terbutylazine‐
desethyl
Herbicide – 68.8 – – – –
Isoproturon Herbicide – 10.1 0.065 2.87 – 1.12 ×
E‐10
Bentazone Herbicide – 9.6 0.5 2.34 2.92 2.18 ×
E‐09
Metolachlor Herbicide – 12.4 0.53 3.13 – 9 × E‐09
Dichlorprop Herbicide – 9.6 0.35 3.43 3.1 8.68 ×
E‐11
Simazine Herbicide – 26.3 0.0062 2.18 1.62 9.42 ×
E‐10
Atrazine‐desethyl Herbicide – 13.8 3.2 1.51 – 1.53 ×
E‐09
Chlortoluron Herbicide – 3.2 0.07 2.41 – –
Hexazinone Herbicide – 0.8 33 1.85 – 2.26 ×
E‐12
Linuron Herbicide – 40.1 0.075 3.20 – –
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Type MP Application Average
concentration
(ng/L) [10, 11]
Solubility*
(mg/mL)
log
Kow*
pKa* Henry’s
constant
(atm-m3/
mole)*Surface
water
WWTP
effluent
2, 4, 5‐T Herbicide – 0.3 0.248 3.26 2.88 6.83 ×
E‐09
Hormone active
substances (effect on
the hormone balance)
[10]
Bisphenol A (BPA) Additive 840 331 0.12 3.32 9.6 1 × E‐11
Estradiol Natural estrogens 2 3 0.0213 4.01 10.33 3.64 ×
E‐11
Estrone Natural estrogens 2 15 0.00394 3.13 10.33 3.8 × E‐10
Nonylphenol Additive 441 267 0.00635 5.99 10.25 1.1 × E‐06
Perfluorooctane
sulfonate (PFOS)
Tenside – – 3.1 6.28 0.14 –
“–”: Data are not available in the literature. *Solubility, log Kow, pKa, and Henry’s law constant for selected
micropollutants are found in http://www.drugbank.ca/, http://chem.sis.nlm.nih.gov/chemidplus/ and https://
pubchem.ncbi.nlm.nih.gov/.
Table 1. Commonly found MPs in municipal wastewater effluent and surface water.
3. Fate and removal processes of MPs in wastewater
The municipal wastewater treatment plants (WWTP) are designed to remove most of the
suspended solids, dissolved organics, and nutrients from the wastewater. WWTPs employ
primary, secondary, and occasional tertiary treatment processes to optimally treat the incoming
wastewater. In primary treatment, coagulants such as alum, ferric chloride, and polymers and
polymeric coagulant aids are used to remove colloidal and suspended particulates. In the
process, organics attached with dissolved humic substances and particles can also be removed.
In secondary treatment, dissolved organics are removed aerobically by a consortium of
microorganisms in suspension. The thickened sludge from both primary and secondary
clarifiers is digested anaerobically (biosolids) prior to disposal. In some places, tertiary
treatment processes such as activated carbon adsorption, ozonation, or filtration are adopted
for final treatment of effluent to remove trace concentration of the organics.
The fate processes for MPs in a typical WWTP include adsorption on suspended particulates,
dissolved humic substances, primary and secondary sludge, while the removal processes
include coagulation and sedimentation, biodegradation, adsorption, advanced oxidation,
and membrane filtration as shown in Figure 1. Volatilization of the MPs during any of the
treatment steps is negligible due to their very low Henry’s constant (<10−5 atm‐m3/mol) as
shown in Table 1.
3.1. Fate: adsorption of micropollutants
Adsorption on suspended solids in both primary and secondary treatment units is an impor‐
tant fate process for MPs in wastewater. Adsorption may occur due to the hydrophobic
interactions between the aliphatic and aromatic groups of the compounds with the fat and
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lipid fractions in primary sludge and the lipophilic cell membrane of the microorganisms in
secondary sludge, respectively. Electrostatic interactions also occur between the positively
charged groups in the MPs and the negatively charged microorganisms in secondary sludge.
Many acidic pharmaceuticals are negatively charged at neutral pH, and their sorption on
sludge is negligible.
Figure 1. Conceptual model of fate and removal processes of a micropollutant in a typical WWTP.
With a nonpolar core and polar moiety, the properties of pharmaceuticals and antibiotics vary
widely, making it difficult to estimate their sorption on sludge. Kinney et al. [12] analyzed
nine different biosolids produced by municipal wastewater treatment plants in seven
different states in U.S. for 87 different MPs, and the measured concentrations of the contam‐
inants in various sludge were in the range of 64–1811 mg/kg dry weight. Nineteen different
pharmaceuticals were detected in these biosolids, representing a wide range of physico‐
chemical properties, including compounds with low log Kow and high water solubility values.
Adsorption of MPs on biosolids did not exhibit any particular trend, and no correlation was
found between organic carbon‐normalized MPs concentrations in biosolids with log Kow,
suggesting that organic carbon content of the biosolids may not be the only factor controlling
MPs adsorption. It is generally expected that compounds with low water solubilities and
large log Kow values will more likely to be present in organic‐rich biosolids compared to highly
soluble organics; however, this study indicated significant presence of water soluble phar‐
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maceuticals in all nine biosolids. The 25 MPs detected in all nine biosolids had water solubility
ranging from 1.3 × 10−5 to 8.28 × 104 mg/L, and log Kow from 1.50 to 9.65 indicating complex
nature of the process. Other factors, such as the quantity of organics entering the influent
stream (which typically varies temporally and spatially), volume of influent, biosolids/water
ratio, and sludge retention time (SRT), all affect the distribution of the MPs in different phases.
Increasing sludge age had detrimental effect on the adsorption of lindane [13] on activated
sludge, adsorption of pentachlorophenol reduced from 40 to 60% at sludge ages below 4 days
to less than 10% at sludge ages above 25 days [14].
The concentrations of some of the commonly found MPs in sludge are summarized in Table 2.
MP Type/application Concentration
(mg/kg)
Source Reference
Triclosan Personal care
product
0.41–46 Sludge (primary, excess
activated, anaerobically
digested)
Heidler & Halden [15],
McAvoy et al. [16]
Triclocarban 4.7–63 Sludge (excess activated,
anaerobically digested)
Heidler & Halden [15],
Tonalide 0.4–2.9 Clara et al. [17]
Galaxolide 4.2–21
Cashmerane 0.022–0.26
Celestolide 0.023–0.061
Phantolide 0.010–0.014
Traesolide 0.29–1.75
Octocrylene 1.01–1.32 Kupper et al. [18]
Octyl‐triazone 2.6–3.04
Octyl‐
methoxycinnamate
0.15–1.5
Pipemidic acid Antibiotic 0.04 –0.27 Sludge (primary, excess
activated, dewatered)
Jia et al. [19]
Fleroxacin 0.02–0.09
Ofloxacin 0.33–7.79
Enrofloxacin 0.02–0.07
Lomefloxacin 0.06–1
Sarafloxacin 0.39–0.13
Gatifloxacin 0.09–0.42
Sparfloxacin 0.01–0.04
Moxifloxacin 0.17–0.56
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MP Type/application Concentration
(mg/kg)
Source Reference
Norfloxacin 1.06–7.23 Sludge (primary, excess
activated, anaerobically
digested, dewatered)
Jia et al. [19], Golet et al.
[20]Ciprofloxacin 0.22–3.1
Azithromycin 2.5–64 Sludge (excess activated,
anaerobically digested)
Gobel et al. [21]
Clarithromycin 0.7–67
Erythromycin 0.030–0.041 Sludge, Class A & B
biosolids
Kinney et al. [12], Ding
et al. [22]
Roxythromycin 0.337–1.446 Anaerobically digested
dewatered sludge
Nieto et al. [23]
Sulfamethoxazole 0.019–68 Sludge (excess activated,
anaerobically digested),
biosolids
Gobel et al. [21], Nieto et
al. [23], Ding et al. [22]
Sulfapyridine 0.1–28 Sludge (excess activated,
anaerobically digested)
Gobel et al. [21]
Sulfamethazine 0.026–0.128 Anaerobically digested
dewatered sludge,
biosolids
Nieto et al. [23], Ding et
al. [22]
Sulfamerazine 0.112–0.669 Biosolids from sewage
sludge
Ding et al. [22]
Chlortetracycline 0.069 –0.346
Oxytetracycline 0.052–0.743
Demeclocycline 0.036–0.131
Tetracycline 0.282–1.914 McCellan & Halden [24],
Ding et al. [22]Doxycycline 0.225–0.966
Trimethoprim 0.017–41 Sludge (excess activated,
anaerobically digested)
Gobel et al. [21], Nieto et
al. [23]
Clindamycin nd–0.006 Municipal sludge Subedi et al. [25]
Lincomycin 0.006–0.174 Municipal sludge,
biosolids
Ding et al. [22], Subedi
et al. [25]
Tiamulin nd–0.7 Agricultural Field soil Schlusener et al. [26]
Tylosin 1.074–1.958 Anaerobically digested
dewatered sludge
Nieto et al. [23]
Acetaminophen Analgesic 0.013–0.419
Carbamezipine 0.011–0.042
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MP Type/application Concentration
(mg/kg)
Source Reference
Diclofenac nd–0.087
Ibuprofen 0.024–0.144
Naproxen nd–0.057
Ketoprofen 0.030 –0.336 Activated sludge Radjenovic et al. [27, 28]
Codeine nd–0.022 Sludge, class A biosolids Kinney et al. [12]
Metoprolol β‐blocker nd–0.021 Anaerobically digested
dewatered sludge
Nieto et al.[23]
Propranolol 0.026–0.044 Radjenovic et al. [28]
Atenolol 0.007–0.084 Sewage sludge Radjenovic et al. [28]
Caffeine Psychoactive drug 0.050–0.074 Anaerobically digested
dewatered sludge,
biosolids
Nieto et al.[23], Ding et
al. [22]
Diltiazem Antihypertension
drug
nd–0.059 Sewage sludge, class A
biosolids
Kinney et al. [12]
Fluoxetine Antidepressant 0.072–1.5 Radjenovic et al. [28]
Paroxetine 0.04 –0.62 Sewage sludge Radjenovic et al. [28]
Gemfibrozil Lipid lowering drug 0.118–0.420 Sewage sludge, class A
biosolids
Kinney et al. [12],
Radjenovic et al. [28]
Bezafibrate nd–0.013 Anaerobically digested
dewatered sludge
Nieto et al. [23]
Clofibric acid 0.007 –0.01
Thiobendazole Antiparasitic drug nd–5 Sewage sludge, class A
biosolids
Kinney et al. [12]
Warfarin Anticoagulant nd – 0.092
Cimetidine Antacid nd–0.071
Diphenhydramine Antihistamine 0.015–7
Miconazole Antifungal drug nd–0.46
Famotidine Antacid 0.03–0.050 Sewage sludge Radjenovic et al. [28]
Loratadine Antiallergic drug 0.052–0.153
Hydrochlorothiazide Diuretic drug 0.011–0.060
Glibenclamide Antidiabetic drug 0.013–0.127
nd‐ not detected
Table 2. Concentrations of commonly found MPs in sludge.
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Although a complex process as described above, the extent of MPs adsorption on sludge is
traditionally modeled using linear equilibrium model as
ads ss dis = dC K C C (1)
where �ads is the adsorbed concentration of the MP (g/L), �ss is the suspended particulate
concentration (g/L), �dis (g/L) is the dissolved concentration, and ��   is the adsorption constant
(L/gss), which is also known as the partition coefficient of the compound between the solids
and water. �� has been proposed as a relatively accurate indicator of adsorption [29, 30]; for
compounds with a �� value below 300 L/kg (log �� = 2.48), the sorption onto secondary sludge
is insignificant. Polar compounds typically have higher �� values in secondary sludge
compared to primary sludge. Typical �� values are presented in Table 3. ��   of a compound
can be correlated to more fundamental properties such as Kow.
Micropollutants log Kow* log Kd log Koc Ref#. Micropollutants log K*ow log Kd log Koc Ref#.
Diclofenac 4.98 1.2041 – b Estradiol 4.01 2.2304 – c
Ibuprofen 3.5 0.8513 – b Estriol 2.45 1.7324 – c
DEET 2.18 1.91 2.27 a Diphenhydramine 3.27 2.5 2.86 a
Clofibric acid 2.57 0.6812 – b Estrone 3.13 2.2304 – c
Ifosfamide 0.86 0.1461 – b Ethinylestradiol 3.67 2.4997 – c
Carbamazepine 2.45 1.95 2.31 a Fenoprofen 3.1 1.415 – c
Hydrocodone 2.16 2.03 2.38 a Fluoxetine 4.05 0.699 – c
Cyclophosphamide 0.63 0.3802 – b Amitriptyline 4.92 2.87 3.21 a
Gemfibrozil 4.77 2.11 2.47 a Gemfibrozil 3.4 1.2856 – c
Diazepam 2.82 1.3222 – b Hydrocodone 1.2 2.0294 – c
Diazepam 2.82 2.14 2.53 a Fluoxetine 4.05 3.08 3.43 a
Ethinylestradiol 3.9 2.5428 – b Indomethacine 4.27 1.4472 – c
Naproxen 3.2 2.16 2.56 a Ketoprofen 3.12 1.2041 – C
Perfluorooctanoic acid 6.3 2.3424 – c Mefenamic acid 5.12 2.6375 – C
Diclofenac 4.51 2.18 2.54 a Methadone 3.93 1.8808 – C
Perfluorononanoic acid 5.48 3.0934 – c Metoprolol 1.88 1.8129 – C
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Micropollutants log Kow* log Kd log Koc Ref#. Micropollutants log K*ow log Kd log Koc Ref#.
Perfluoroundecanoic acid 6.9 3.3581 – c Morphine 0.89 1.0792 – C
Ketoprofen 3.12 2.25 2.64 a Naproxen 3.18 1 – C
Bisphenol A 3.32 2.28 2.64 a Primidone 0.91 1.699 – C
Amoxycillin 0.87 0.0253 – c Propranolol 3.48 2.5353 – C
Amitriptyline 4.92 2.8698 – c Risperidone 2.5 2.73 – C
Trimethoprim 4.9 2.3 2.65 a Roxithromycin 1.7 1.7076 – C
Androstenedione 2.75 2.1271 – c Sotalol 0.24 1.2553 – C
Aspirin 1.19 0.3464 – c Sulfadimethoxine 1.63 0.4771 – C
Ibuprofen 3.97 2.32 2.64 a Sulfamethazine 0.89 1.301 – C
Atorvastatin 5.7 1.9685 – c Sulfamethoxazole 0.89 1.0414 – C
Azithromycin 4.02 2.4472 – c Sulfapyridine 0.35 0 – C
Bezafibrate 3.97 1.9395 – c Testosterone 3.32 2.1335 – C
Benzophenone 3.18 2.1335 – c Tramadol 2.4 1.6721 – C
Bisoprolol 1.87 1.6021 – c Trimethoprim 0.91 1.4048 – C
Dilantin 2.47 2.49 2.84 a Triclosan 4.76 3.59 3.95 A
Celiprolol 2.29 1.9294 – c Triclocarban 4.9 4.41 4.76 A
Clarithromycin 3.16 2.415 – c Diazepam 2.82 1.301 – C
Clofibric acid 2.84 0.699 – c Diphenhydramine 3.27 2.4997 – C
Codeine 1.19 1.1461 – c Erythromycin 2.37 1.4456 – C
“–“: Data are not available in the literature. *log Kow for selected MPs are found in http://www.drugbank.ca/. # log Kd
and log Koc values are collected from references (Ref.) as follows: (a) [31], (b) [30], (c) [32].
Table 3. log Kd and log Koc values of some commonly found MPs.
As mentioned before, the sorption to sludge is not significant for compounds with log Kow <
2.5, moderate sorption for log Kow between 2.5 and 4, and high sorption for log Kow > 4.0 is
expected. In absence of experimental data, to relate �� with Kow, Eqs. (2) and (3) are given by
Matter-Muller et al. [33] and Dobbs et al. [34], respectively:
owlog  0.67  log  0.39= ´ +dK K (2)
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owlog  0.58 log  1.14= ´ +dK K (3)
�� can also be estimated using Eq. (4) (Fetter [35]) and Eq. (5) (Jones et al. [36]) if the fractionof organic carbon of the solids is known as
ow0.72  log  0.49
oc
10  1000
´ +
= ´
K
dK f (4)
oc ow    0.41   = ´ ´dK f K (5)
values of �� and �oc versus �ow for MPs from the literature are plotted in Figure 2 showingslightly lower linear dependence of �� and �oc on �ow as compared to Eqs. (2) and (3). Inaddition, the goodness of fit as indicated by R2 is in the range of 0.45–0.48, indicating possible
influence of other parameters than only �oc or �ow.
Figure 2. Correlation between log Kd versus log Kow and log Koc versus log Kow for MPs listed in Table 3.
MP adsorption on sludge mostly follow linear isotherm such as Fruendlich:
1/  . = ne f eq K C (6)
where �e  =  mass adsorbed per unit mass of adsorbent at equilibrium (mg/g)
Ce = concentration of MP in water at equilibrium (mg/L)
Physico-Chemical Wastewater Treatment and Resource Recovery88
1� = strength of adsorption (dimensionless)�� =  adsorption capacity at unit concentration (mg/g)(L/mg)1/�
The values of ��   and 1/n for MPs on sludge varied from 0.0052 to 4.40 (mg/g) (L/mg)1/n and
0.51 to 1.0076, respectively [37–40]. Larger �� values indicate higher affinity of adsorption for
a particular sludge and closer the value of 1/n around 1.0, greater is the indication of compa-
ratively strong adsorption bond. Typically, adsorption equilibrium is achieved within 24 hours
with almost 90% removal from dissolved phase occurs in an hour; for example, at 3.6 g/L mixed
liquor suspended solids (MLSSs) concentration, 95% of oxytetracycline was removed from
water within only 1 hour and the concentration at equilibrium remained unchanged over 24
hours [40].
Colloidal particles are a relatively small fraction of the total waterborne particle mass (<10%)
in typical wastewater but possess large surface areas which can enable covalent, electrostatic,
and hydrophobic binding of MPs depending on their polarity. The magnitude of sorption
depends on the molecular weight distribution and aromatic content of the colloids fraction,
which also depends on the sewage composition, strength, and sludge age [41]. Similar to
adsorption on suspended particulates, adsorption on colloidal particles can be quantified using
a distribution coefficient Kcoc. Holbrook et al. [41] determined Kcoc using pyrene as a model MP
and colloidal fractions from two biological wastewater plants; sorption coefficients (Kcoc) for
pyrene ranged from 1 × 103 L/kg colloids to 80 × 103 L/kg colloids and were comparable to
values obtained in the literature for natural organic matter. Good correlation was obtained
between Kcoc and the aromaticity of the colloidal particles.
3.2. Removal processes
3.2.1. Coagulation and sedimentation of micropollutants
Coagulation-flocculation processes are typically used for improving efficiency of wastewater
treatment plants promoting the removal of suspended solids, colloids, and some dissolved
organics, which do not settle spontaneously. The coagulation process works by destabilizing
the colloids/emulsions using coagulants such as metal salts and/or synthetic organic polymers
following any of the mechanisms such as double-layer compression, adsorption and charge
neutralization, entrapment of particles in precipitate, adsorption and interparticle bridging.
The parameters that affect the performance of coagulation are coagulant dosage, pH, and ionic
strength of the solution. Based on the type of coagulant such as aluminum sulfate, ferrous
sulfate, and ferric chloride, optimum pH range for coagulation varies between 4.0 and 8.5. In
case of polymeric coagulants, the active group (carboxyl, amino group, etc.) present on the
polymer influences the change of charge with pH [42].
In general, removal of MPs by coagulation-flocculation processes is not very effective for most
of the compounds studied with a few exceptions. Earlier studies on removal of MPs by
coagulation were reported for simulated drinking water treatment processes [43–47], and
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percent removal of various MPs varied from 15 to 75% using alum and iron salts, and excess
lime/soda ash softening. Vieno et al. [46] evaluated the role of dissolved organic matter, mainly
the humic substances in the coagulation process. In the presence of dissolved humic matter,
diclofenac, ibuprofen, and bezafibrate could be removed by ferric sulfate coagulation. The
removal of diclofenac reached a maximum of 77%, while 50% of ibuprofen, and 36% of
bezafibrate were removed. Hence, a high amount of high-molecular-weight dissolved organic
matter enhanced the removal of ionizable pharmaceuticals. However, contradictory results
were reported by Choi et al. [43] where removal of seven tetracycline classes of antibiotic (TAs)
from synthetic and river water using coagulation was achieved. TAs were assumed to be
removed through the charge neutralization of zwitterionic or negative TAs by cationic Al (III)
and sweep coagulation using poly-aluminum chloride (PACl). Aluminum hydroxide precip-
itates were formed in the presence of sufficient alkalinity, and TAs were removed by being
enmeshed into or adsorbed onto the precipitates. It was suggested that the presence of
dissolved organic matter, especially the low-molecular-weight fractions, resulted in possible
inhibition of MP removal. This was due to preferential removal of the organic matter by the
coagulant.
Huerta-Fontela et al. [48] performed coagulation with alum-coagulants, flocculation with a
diallyldimethyl ammonium chloride homopolymer (poly-DADMAC), followed by clarifica-
tion through sand filters. Of the 55 pharmaceutical compounds present, only five compounds
(chlordiazepoxide, zolpidem, bromazepam, clopidogrel, and doxazosin) were completely
removed, while warfarin, betaxolol, and hydrochlorothiazide accounted for removals higher
than 50%. For some pharmaceuticals such as irbesartan, losartan, or carbamazepine epoxide,
negligible removals were obtained.
Suarez et al. [49] evaluated the performance of coagulation-flocculation process for the
pretreatment of hospital effluent, both in a batch mode and continuous pilot scale. Highest
removal efficiency (>90%) was reported for PPCPs such as galaxolide, tonalide, and synthetic
musk (ADBI); these are lipophilic compounds, carrying high negative charge, which facilitates
their coagulation in the presence of higher fat content in wastewater. Asakura and Matsuto [50]
studied the effect of coagulation for treating landfill leachate. Out of the various EDCs, only
nonylphenol showed a removal of >90%, whereas diethylhexylphthalate (DEHP) removal was
about 70%. Other EDCs such as diethylphthalate (DEP), dibutylphthalate (DBP), butylben-
zylphthalate (BBP), 4-t-octylphenol (4tOP), and 4-n-octylphenol (4nOP) showed poor removal
(<50%) by coagulation, with the lowest removal of 20% for bisphenol A.
Few studies have reported the removal of MPs due to coagulation and flocculation in waste-
water (Table 4). Matamoros and Salvadó [51] evaluated several MPs removal in a coagulation/
flocculation-lamellar clarifier for treating secondary effluent. The hydrophobicity of the
compounds (log Kow) was found to be a major factor in determining the removal efficiency with
coagulation-flocculation. The highest removal of 20–50% was observed for the compounds
with log Kow ≥ 4 at pH 7–8. Since adsorption of MPs on the suspended solids and colloids is
the precursor step for their removal during coagulation, the removal efficiency can be tied with
the removal efficiency of suspended solids as
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% removal    1  = +
d
d
K C EK C (7)
where ETSS is the efficiency of TSS removal (%) during coagulation.
Carballa et al. [52] observed that during coagulation-flocculation of primary wastewater,
lipophilic compounds such as musks were adsorbed in the lipid fractions of the sludge with
two different fat concentrations of 60 and 150 mg/L, while acidic compounds such as
diclofenac were adsorbed due to electrostatic interaction. Compounds with high sorption
properties (galaxolide and tonalide) and diclofenac were significantly removed during
coagulation-flocculation with efficiencies around 70%. Compounds with lower Kd values,
such as diazepam, carbamazepine, ibuprofen, and naproxen, were reduced to a lesser extent
(up to 25%).
Coagulant Dosage(ppm) with
pH
compound Source Removal
(%) 
Reference
Ferric chloride/
aluminum
sulfate
25, 50–pH 7 Ibuprofen Hospital wastewater 12.0 ± 4.8 Suarez et al. [49]
Diclofenac 21.6 ± 19.4
Naproxen 31.8 ± 10.2
Carbamazepine 6.3 ± 15.9
Sulfamethoxazole 6.0 ± 9.5
Tonalide 83.4 ± 14.3
Galaxolide 79.2 ± 9.9
Ferric chloride 100, 200–pH(4, 7, 9) Bisphenol A Landfill leachate 20 Asakura and Matsuto
[50]DEHP 70
Nonylphenol 90
Not mentioned Sulfamethoxazole Drinking water
treatment plant
33 Stackelberg et al. [47]
Acetaminophen 60
Cholesterol 45
Diazenon 34
Metachlor 28
Aluminum
sulfate
200–pH 7 Aldrin Surface water 46 Thuy et al. [53]
100–pH 7 Bentazon 15
78–pH 6.8 Estradiol Drinking water
treatment plant
2 Westerhoff et al. [45]
Estrone 5
Progesterone 6
Fluoxetine 15
Hydrocodone 24
Chlordane 25
Benzanthracene 26
Chrysene 33
Erythromycin 33
DDT 36
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Coagulant Dosage(ppm) with
pH
compound Source Removal
(%) 
Reference
Heptachlor 36
Aldrin 49
Benzofluoranthine 70
Benzopyrene 72
Ferric sulfate 78.5–pH 4.5 Dichlofenac Lake water with
dissolved humic acid
77 Vieno et al. [46]
Ibuprofen 50
Bezafibrate 36
Carbamazepine <10
Sulfamethoxazole <10
– – Celestolide Secondary effluent
from WWTP
50 Matamoros and
Salvadó [51]Tricholsan 24
Octylphenol 50
Tonalide 24
DMP 19
Galaxolide 16
Ibuprofen 4
Carbamazepine 2
“–“: Data are not available in the literature. *log Kow for selected MPs are found in http://www.drugbank.ca/. # log Kd
and log Koc values are collected from references (Ref.) as follows: (a) [31], (b) [30], (c) [32].
Table 4. Removal of MPs by coagulation/flocculation process from various effluents.
3.2.2. Biodegradation of micropollutants in secondary treatment
Most of the conventional municipal WWTPs do not remove complex MPs by biodegrada‐
tion and/or biotransformation effectively. Observed removal efficiencies vary in a wide
range for different compounds, as well as for the same substance, due to operational condi‐
tions such as aerobic, anaerobic, anoxic, sludge retention time (SRT), pH, redox potential,
and water temperature. Membrane bioreactors (MBRs) seem to be more effective than con‐
ventional‐activated sludge (CAS) process as MBR process combines biological treatment
with membrane filtration (micro and ultrafiltration). In addition, due to higher SRT at
MBRs compared to CAS, biodiversity of the microorganisms in MBR is greater than CAS,
and opportunity for adaptation of specific microorganisms to the persistent compounds is
greater in MBR than in CAS. Removal of 29 antibiotics in a CAS process was reviewed by
Verlicchi et al. [54], where removal of compounds such as sulfamethoxazole, ciprofloxacin,
roxithromycin, norfloxacin, erythromycin, etc., varied in a wide range of 0 (spiramycin)
and 98% (cefaclor) in CAS and between 15 (azithromycin) and 94% (ofloxacin) in MBRs.
Only 1 (azithromycin) out of 10 compounds investigated in both systems exhibited higher
average removal efficiency in CAS than in MBR. Trinh et al. [55] traced 48 MPs including
steroidal hormones, xenoestrogens, pesticides, caffeine, pharmaceuticals, and personal care
products (PPCPs) in a MBR with >90% removal for many of the compounds. However,
amitriptyline, carbamazepine, diazepam, diclofenac, fluoxetine, gemfibrozil, omeprazole,
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sulphamethoxazole, and trimethoprim were only partially removed in MBR with the re‐
moval efficiencies of 24–68% [55]. Similar results were obtained in a pilot‐scale MBR oper‐
ated for a Swiss hospital effluent for 1 year [56, 57]. Among the 56 pharmaceuticals, an
overall load elimination of all pharmaceuticals and metabolites in the MBR was only 22%
due to the presence of persistent iodinated contrast media (almost 80% of the total organic
load). Weiss and Reemtsma [58] reported that major advantage of MBR lies for the com‐
pounds with moderate removal in CAS; MBR showed no advantages for both well‐degrad‐
able and recalcitrant compounds. For polar compounds, MBR does not provide significant
benefits, because effluent quality is improved only gradually and the most critical compo‐
nents of high aerobic stability remain almost unaltered [58].
Longer SRT as required for nitrogen removal also played an important role in reducing the
concentrations of certain MPs [59, 60], and a SRT > 10 days was recommended. Longer SRTs
resulted in diverse growth of the microbial community including the growth of nitrifying
bacteria. Nitrifying bacteria had shown potential for cometabolic degradation of MPs [61, 62].
However, much longer SRT (49 days) was required for 61% removal of iopromide compared
to zero removal in CAS [61]. Mixed bacterial cultures also have proved to be quite effective in
removing MPs such as triclosan, BPA, and ibuprofen in river [63, 64] and WWTP [65, 66]. While
MPs such as quaternary ammonium compounds are biodegraded as single compound, their
biodegradation is inhibited in a mixture using Pseudomonas sp. isolated from returned activated
sludge [67].
Although an important process variable, hydraulic retention time (HRT) shows varied results
for the removal of MPs in WWTP indicating that further research is required on this. A study
conducted by Wever et al. [57] reported that decreasing the HRT in a CAS resulted in
increasing the concentrations of MPs such as 2, 6 and 1, 6 NDSA; however, it did not affect
the percent removal of these compounds in a MBR. In case of pharmaceutical and fragrance
compounds, Joss et al. [29] reported that HRT played a very minor role when considering a
time period of 0.7 hours for fixed bed reactor, 13 hours for a MBR, and 17 hours for a CAS
process.
Solution pH plays a significant role in the removal of MPs as the highly acidic or highly basic
solutions affect the solubility of the MPs and also hinder growth of the microbial community
[68]. As listed in Table 1, MPs exhibit a wide range of pKa values. At pH range of 6–8, as found
in most wastewater, many antibiotics and other MPs with pKa values in this range will be
ionized. For example, about 40% of pharmaceuticals contain at least one functional group with
pKa values in the range of 5–10 [69]. The degree of speciation of such ionizable compounds
and their subsequent adsorption and biotransformation will be affected by pH.
The microbial growth and activity, as well as solubility and other physicochemical properties
of MPs, are significantly affected by temperature. Temperature variability has been related to
deterioration in bulk water quality and system instability; it has also been linked to sludge
deflocculation and decreased sludge metabolic activity [70]. Vieno et al. [71] reported that the
removal of ibuprofen, diclofenac, benzafibrate, ketoprofen, and naproxen increased during the
summer (average temperature 17°C) and decreased in the winter (average temperature 7°C).
However, Lesjean et al. [72] reported that in a conventional WWTP, temperature variation
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between 12 and 25°C brought about little or no change to the degradation process of MPs
whereas for a MBR the removal rates were greatly affected by the seasonal changes. Hai et al.
[70] reported that the removal of most hydrophobic compounds (log Kow > 3.2) in a MBR was
stable in the temperature range of 10–35°C, while for less hydrophobic compounds, significant
variation occurred in the lower temperature regimes (10–35°C). Lower and more variable
removal efficiency at 10°C was observed for certain hydrophilic compounds, which have been
reported to be moderately recalcitrant in MBR treatment.
No quantitative relationship between structure and activity can be found for the biological
transformation. Overall, it can be concluded that for compounds with a sorption coefficient
(Kd) below 300 L/kg, sorption onto secondary sludge is not relevant, and their transformation
can consequently be assessed simply by comparing influent and effluent concentrations.
At low dissolved concentration, the kinetics of biodegradation/biotransformation of MPs
follow first order as
bio ss disrate  = K C C (8)
where   �bio   is the biodegradation rate constant, �ss   is  the suspended solids concentration,
and �dis   is the dissolved concentration of MPsss. Typically, complex aromatic structure with
more than one benzene ring and/or with chlorine and nitro groups are not efficiently
biodegraded [32, 73]. The aerobic biodegradation constants of 20 aromatic species using
activated sludge were reported, and the kinetic constants were correlated to the structure of
the molecules [73]. The normalized first-order rate constants �bio  (L/gss/h) using �ss (g/L)
were 0.003, 0.02, and 3.80 for 3, 5 dinitrobenzoic acid, 2, 6 dichlorophenol, and benzoic acid,
respectively. Pomiesa et al. [32] summarized a list of both aerobic and anaerobic rate constants
for 20 pharmaceuticals including antibiotics, and other compounds such as bisphenol A and
nonylphenol, and the aerobic �bio  (L/gss/h) varied from 0.0025 to 7.08 with carbamazepine
being the lowest, and galaxolide (a synthetic fragrance) being the highest biodegradable
compound. The difference in rate constants for aerobic and anaerobic conditions is less than
15% for some substances (e.g., celestolide and galaxolide) or can be much higher in some
other cases (e.g., >50% for estradiol and roxithromycin). Compounds with kbio < 0.0042 L/gss/
h are not removed significantly (<20%), whereas compounds with kbio > 0.4 L/gss/h can be
transformed by >90%. Therefore, with the existing biological treatment schemes in municipal
wastewater, 90% of the MPs are not removed or biotransformed. Many of the plant data do
not distinguish between adsorption and biotransformation due to challenging chemical
analyses. In most cases, overall removal is estimated based on the influent and effluent
concentrations, and information about the intermediate steps is either missing or not reliable
[74]. Other challenges are the fate of metabolites, transformation products of pharmaceuticals,
and complex chemistry involving these compounds with background water quality, which
are all unknown at this point.
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Tertiary treatment of wastewater using various combinations of membrane processes,
activated carbon adsorption, and advanced oxidation are being performed or characterized
in various jurisdictions with stringent water quality requirements. Above technologies all
work well for the removal of trace concentration of organics in lab studies and will be
described below.
3.2.3. Activated carbon adsorption
Adsorption as a unit operation using either granular‐ or powder‐activated carbon (GAC and
PAC) to remove organics from water metrics is well established. The mechanism of adsorption,
relevant parameters, and adsorption models discussed in the section of adsorption on sludge
are applicable for GAC and PAC adsorption. In absence of experimental data on adsorption
isotherm, a correlation developed by Crittenden et al. [75] combining Polanyi potential theory
and linear solvation energy relationships (LSERs) can be used.
Activated carbon adsorption for the removal of MPs has been applied in both secondary and
tertiary treatment units. Simultaneous adsorption of sulfamethoxazole and carbamazepine to
powdered‐activated carbon (PAC) in a membrane bioreactor (MBR) was reported at PAC
dosage of 0.1–1 g/L [76–78]. Altmann et al. [77] compared the performance of PAC and
ozonation for seven MPs from four different wastewater plants. Typical dosages were about
20 mg/L of PAC and 5–7 mg/L of ozone, respectively, and the performances of both technologies
were very much dependent on the type of pollutants. Hydrophobic compounds with log Kow
> 5 have much better removal potential by adsorption than polar compounds, with the
exceptions of some protonated bases and deprotonated acids. Empty bed contact time (EBCT)
for a biological‐activated carbon filter for the removal of numerous MPs for three full‐scale
reclamation plants varied from 9 to 45 min.
3.2.4. Membrane processes
Membrane‐based process systems can be classified as direct membrane‐based, integrated
membrane‐based, and combined direct and integrated membrane system. Pressure‐driven
membrane filtration processes, such as nanofiltration (NF), ultrafiltration (UF), microfiltration
(MF), and reverse osmosis (RO), are routinely used for various effluent treatments. While MF
and UF are low‐pressure processes, NF and RO are high‐pressure processes. In tertiary
treatment of wastewater for MPs, UF and NF can be effectively used. The removal of MPs by
membrane depends on many different factors including characteristics of membrane, MP,
aqueous media/solute characteristics, operating conditions, and membrane fouling. The
fundamental mechanism of membrane filtration is size exclusion, although adsorption due to
hydrophobic interactions, electrostatic repulsion, and adsorption on fouling layer all can play
a part [79–82]. Size exclusion mechanism is mostly applicable to noncharged MPs, however,
shape of the molecule should also be taken into consideration. Hydrophobic interaction and
hydrogen bonding contribute to the adsorption of MPs on the membrane surface. Membrane
fouling and the presence of dissolved organic carbon could also increase adsorption by
changing the membrane surface characteristics and pore size. For charged MP, electrostatic
interaction between the compound and membrane surface gives rise to electrostatic exclusion
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for membrane surfaces with like charges. Figure 3 shows the four mechanisms of MP removal
by membrane processes. Membrane‐based processes have several advantages such as good
adaptability, high removal rate, robustness, and no harmful intermediates are formed. An
overview of research at laboratory, pilot and full‐scale applications of MPs removal is pre‐
sented in Table 5.
Figure 3. Micropollutants removal mechanism in polymeric membranes. (a) size exclusion, (b) adsorption (hydropho‐
bic interaction), (c) electrostatic repulsion, and (d) adsorption (fouling layer interaction) (concept adopted from Ojajuni
et al. [83]).
MPs % Removal Remarks Reference
11 MPs 500 μg/L, (pharmaceuticals and
pesticides)
>70% UF and NF; laboratory scale;
secondary effluent
Acero et al. [84]
80 MPs; Metals 18–265 μg/L, VOC 0.65–7.10
μg/L, PAH 0.23–0.67 μg/L, and HVOC 1.45–
12.17 μg/L
∼40–50% removal for
metals
UF; full scale; secondary
clarified effluent
Battistoni et al.
[85]
Macrolides, roxithromycin (ROX),
clarythromycin (CLA), erythromycin (ERY),
sulfonamides, and
trimethoprim:sulfamethazine (SMZ),
sulfamethoxazole (SMX), and trimethoprim
(TMP)
45– 94% Full scale UF; raw sewage of
WWTP
Sahar et al. [86]
Pharmaceutically active contaminants
(PhACs): sulfamethoxazole, carbamazepine,
and Ibuprofen (500 μg/L)
50–85% NF; laboratory scale; spiked
synthetic solution
Nghiem et al.
[87]
EDCs–estrone, estradiol, and salicin at initial
concentration of 1 mg/L
85±/4% for estradiol,
65±/3% for estrone,
91±/1% for salicine
NF; laboratory scale; spiked
synthetic solution
Braeken and
Van der
Bruggen [88]
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MPs % Removal Remarks Reference
Pesticide endosulfan (10–100 μg/L) 84–96% NF; laboratory scale; spiked
synthetic solution
De Munari et
al. [89]
11 neutral EDCs and PhACs at initial
concentration of 100 μg/L
0–91% RO; laboratory scale; synthetic
solution
Kimura et al.
[90]
22 EDCs and pharmaceutically active
compounds (PhAC)‐ ∼ 1 μg/L
variable removal in NF;
>90% removal in
RO
Loose and tight NF; RO;
bench scale; surface water;
effluent of MBR of WWTP
Comerton et al.
[91]
PhACs: carbamazepine, diclofenac, and
ibuprofen (IBU) l concentration 0.025–0.1
μg/L
31–39% removal for
carbamazepine; 55–61%
removal of ionic
diclofenac and ibuprofen
NF; laboratory; drinking
water
Vergili [92]
22 compounds representing pharmaceutically
active compounds, pesticides, hormones and
industrial chemicals; 5 μg/L
80–99% MBR; laboratory; spiked
synthetic municipal
wastewater
Hai et al. [70]
bisphenol A (750 μg/L), sulfamethoxazole
(750 μg/L)
90% removal for
Bisphenol A; 50% for
sulphamethoxazole
MBR (submerged); laboratory;
secondary effluent spiked
Nghiem et al.
[93]
40 organic compounds above 85% for
hydrophobic compounds;
less than 20% for the rest
MBR; laboratory;secondary
effluent spiked
Tadkaew et al.
[80]
Ionisable trace organics :sulfamethaxozale,
ibuprofen, ketoprofen, and diclofenac at 2
μg/L
Removal dependent on
mixed liquor pH.
MBR (submerged); laboratory;
synthetic wastewater
Tadkaew et al.
[94]
56 pharmaceuticals, 10 metabolites, and two
corrosion inhibitors at concentration from 0.1
μg/L to 2.6 mg/L
Removal varies MBR; pilot scale; wastewater
directly from the hospital
sewer collection system
Kovalova et al.
[56]
11 emerging contaminants: acetaminophen,
metoprolol, caffeine, antipyrine,
sulfamethoxazole, flumequine, ketorolac,
atrazine, isoproturon, 2‐hydroxybiphenyl,
and diclofenac(all at 0.5 mg/L)
UF with GAC
posttreatment performed
better than UF with PAC
pretreatment.
UF combined with PAC
(pretreatment) and GAC
(posttreatment), secondary
effluent spiked
Acero et al. [95]
6 antibiotics, 3 pharmaceuticals (ibuprofen,
salicyclic acid, and diclofenac) and Bisphenol
A
>90% MBR‐RO, pilot plant, real
wastewater
Sahar et al. [96]
PPCPs; acetaminophen, atenolol,
carbamazepine, clopidogrel, diclofenac,
dilantin, ibuprofen, iopromide, glimepiride,
naproxen, and sulfamethoxazole
Up to 95% MBR‐NF; laboratory; real
wastewater
Chon et al. [81]
10 micropollutants detected in wastewater
including carbamazepine, ibuprofen, and
caffeine
>76.9% MBR‐NF and MBR‐RO; pilot
plant; real wastewater
Cartagna et al.
[97]
9 pharmaceuticals, bezafibrate,
carbamazepine, clofibric acid, diclofenac,
gemfibrocil, ibuprofen, ketoprofen, naproxen,
and fenofibric acid
60–80% MBR‐PAC (submerged); pilot
plant; WWTP primary
pollutant
Lipp et al. [98]
Table 5. Membrane systems for micropollutants removal in different scales.
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3.2.5. Advanced oxidation processes
Advanced oxidation processes (AOPs) using hydroxyl radicals (OH•) are increasingly used
for tertiary treatment of municipal wastewater and for water recycling. These processes are
fast, nonselective, and effective for recalcitrant compounds. Among numerous combinations
of AOPs, UV‐, hydrogen peroxide‐, and ozone‐based processes are easy to implement for
tertiary treatment of WWTP effluent. In a comprehensive research, removal efficiency of 220
MPs with postozonation was studied at full scale for a WWTP [1]. Compounds with activated
aromatic moieties, amine functions, or double bonds such as sulfamethoxazole, diclofenac, or
carbamazepine had second‐order rate constants for ozonation >104/M/s at pH 7 (fast reacting)
were eliminated to concentrations below the detection limit for an ozone dose of 0.47 g O3/g
DOC. Higher ozone dosage of 0.6 g O3/g DOC was needed for more recalcitrant compounds
such as atenolol and benzotriazole for >85%. Rahman et al. [99] summarized the second‐order
ozone and OH• oxidation constants for commonly found EDCs and pharmaceuticals in pure
water, which varied from 0.8 to 7 × 109 and 1.2 × 109 to 9.8 ×109 /MS, respectively. In wastewater,
rates will be somewhat lower due to the competition of background organics, suspended
particulates, and radical scavengers. However, the effect of background organics competition
was found to be minimal for estrone degradation in wastewater by Sarkar et al. [100]. The
overall cost of ozonation was found to be lower than that of UV/H2O2 process for estrone
degradation, although electrical energy per order was lower for UV/H2O2. AOPs are effective
in a wide range of pH (i.e., 4–11) depending on the type of target compounds; although
ozonation is more effective in alkaline pH. In some cases, transformation products that form
due to AOPs may be even more toxic compared to parent compounds. For example, inter‐
mediates of UV/H2O2 oxidation of bisphenol A exhibited different estrogenic activity depend‐
ing on the treatment conditions [101]. Whole effluent analysis methods are better for assessing
the toxicity of resulting water instead of time‐ and labor‐intensive chemical analyses.
4. Conclusion
Fate and removal processes of micropollutants (MPs) in wastewater treatment are complex,
and difficult to assess due to tedious and cost‐intensive analyses. However, these processes
can be somewhat estimated based on their physical properties such as log Kow, pKa, and
solubility. Adsorption on colloidal and suspended particles and subsequent removal in sludge
may occur for compounds with log Kow > 4.0. Majority of the MPs are not removed in conven‐
tional‐activated sludge process, although better removal for some cases occurs in membrane
bioreactors due to greater diversity and adaptability of microorganisms. Compounds with
biological degradation constant <0.0042 L/gss/h are not removed significantly (<20%), whereas
compounds with rate constants >0.4 L/gss/h can be transformed by >90%. Tertiary treatment
of wastewater effluent using activated carbon adsorption, membrane filtration, and advanced
oxidation processes are capable of removing MPs with varying degrees of success, although
both lab and pilot‐scale studies are required to establish their rates of removal. In the case of
intermediates or transformation, products are produced during a treatment, whole effluent
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analysis using a bioassay is a better method to evaluate the quality of effluent instead of
conducting compounds specific chemical analyses.
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